Fellowship, Hematopathology, University of Michigan, Department of Pathology, Ann Arbor, MI
2007:
Residency, Clinical Pathology, University of Michigan, Department of Pathology, Ann Arbor, MI
2004:
MD/PhD, Cellular and Molecular Biology, University of Michigan Medical School, Medical Scientist Training Program, Ann Arbor, MI
1996:
BS, Biochemistry and Molecular Biology
Second Major in English and American Literature, Brown University, Providence, RI
Work Experience
2009 to Present:
Pathologist, Marshfield Labs, a Division of Marshfield Clinic Inc., 701 Kalsched Street, Marshfield, WI
2008 to 2009:
Clinical Lecturer, University of Michigan - Department of Pathology, Ann Arbor, MI
Board Certifications
2008 to 2021:
American Board of Pathology - Clinical
2008 to 2021:
American Board of Pathology - Hematopathology
Honors & Awards
1996:
Magna Cum Laude, Brown University
2004:
AMWA Glasgow - Rubin Achievement Citation
2008:
AACR Molecular Biology in Clinical Oncology Workshop
Professional Societies
American Society of Clinical Pathology, Member
Wisconsin Medical Society, Member
Select Publications
Misobe T, Maghsoudi K, Sitwala KViren, Tianzhi G, Ou J, Maze M. (1996 September). Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat. JOURNAL OF CLINICAL INVESTIGATION. 98(5):1076-80.
PubMed ID:
8787667
Sitwala KViren, Adams K, Markovitz DM. (2002 December). YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. ONCOGENE. 21(57):8862-70.
PubMed ID:
12483538
Sitwala KViren, Mor-Vaknin N, Markovitz DM. (2003 June). Minireview: DEK and gene regulation, oncogenesis and AIDS. ANTICANCER RESEARCH. 23(3A):2155-8.
PubMed ID:
12894590
Adams BS, Cha HC, Cleary J, Haiying T, Wang H, Sitwala KViren, Markovitz DM. (2003). DEK binding to class II MHC Y-box sequences is gene- and allele-specific. ARTHRITIS RESEARCH & THERAPY. 5(4):R226-33.
PubMed ID:
12823858
Mor-Vaknin N, Punturieri A, Sitwala KViren, Markovitz DM. (2003 January). Vimentin is secreted by activated macrophages. NATURE CELL BIOLOGY. 5(1):59-63.
PubMed ID:
12483219
Cleary J, Sitwala KViren, Khodadoust MS, Kwok RP, Mor-Vaknin N, Cebrat M,...Markovitz DM. (2005 September). p300/CBP-associated factor drives DEK into interchromatin granule clusters. JOURNAL OF BIOLOGICAL CHEMISTRY. 36(3):31760-7.
PubMed ID:
15987677
Sitwala KViren, Hess JL. (2006 April). Structural basis of multimer-mediated mayhem. CANCER CELL. 9(4):241-2.
PubMed ID:
16616328
Mor-Vaknin N, Punturieri A, Sitwala KViren, Faulkner N, Legendre M, Khodadoust MS,...Markovitz DM. (2006 December). The DEK nuclear autoantigen is a secreted chemotactic factor. MOLECULAR AND CELLULAR BIOLOGY. 26(24):9484-96.
PubMed ID:
17030615
Oravecz-Wilson KL, Philips ST, Yilmaz OH, Ames HM, Li L, Crawford BD,...Ross TS [including Sitwala KViren.] (2009 August). Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. CANCER CELL. 16(2):137-8.
PubMed ID:
19647224
Muntean A, Tan J, Sitwala KViren, Huang Y, Bronstein J, Connelly JA,...Hess JL. (2010 June). The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. CANCER CELL. 17(6):609-21.
PubMed ID:
20541477
Huang Y, Sitwala KViren, Bronstein J, Sanders D, Dandekar MN, Collins C,...Hess JL. (2012 January). Identification and characterization of Hoxa9 binding sites in hematopoietic cells. BLOOD. 119(2):388-98.
PubMed ID:
22072553
Rafiullah, Islam R, Mahmood R, Sitwala KViren. (2013 July). Gelatinous bone marrow transformation secondary to unusual eating habits and drastic weight loss. BMJ Case Rep.. :pii: bcr2013200243.
PubMed ID:
23861277